India Corona (Covid-19) Update: Pfizer, which is ready to offer 5 crore doses to India between July and October this year and has sought certain relaxations including indemnification. As India is facing an acute shortage of vaccines at home, Pfizer has informed the Centre, during a series of interactions, that its COVID-19 vaccine is suitable for all aged 12 and above, and can be stored at 2-8 degrees for over a month. They also discussed indemnity protection against liabilities before they bring vaccines to India. More than 20 crore Indians have been vaccinated against Covid-19, with at least 15.71 crores having taken their first dose and 4.35 crore their second, data from the Ministry of Health showed on Thursday.
Delhi Chief Minister Arvind Kejriwal on Thursday sought procurement of Pfizer’s Covid-19 vaccine as soon as possible to inoculate children. This comes after the US pharma company sought fast-track approval for its jab in India. The US major has told Indian authorities that its vaccine is suitable for everyone aged 12 years or above and can be stored for a month at 2-8 degrees. “We shud procure this vaccine asap for our children,” Kejriwal tweeted.
The vaccine was “Well tolerated with side effects generally consistent with those observed in participants 16 to 25 years of age,” companies said Earlier.
U.S. major Pfizer has told Indian authorities that its jab has shown “high effectiveness” against the SARS-CoV-2 variant prevalent in India and on people of Indian ethnicity or nationality, while it is suitable for everyone aged 12 years or above and can be stored for a month at 2-8 degrees, sources said on Wednesday.